title: Transient tachypnea of the newborn (TTN): a role for polymorphisms of surfactant protein B (SP-B) encoding gene?
abstract: BACKGROUND
  Transient tachypnea of the newborn (TTN) is usually a benign self-limiting respiratory disorder in the immediate neonatal period. The lipophilic surfactant-associated protein B (SP-B) was demonstrated to be the most relevant structural component of the surfactant system for immediate postnatal pulmonary adaptation. We hypothesized genetic variations of surfactant protein B (heterozygous 121 ins 2 mutation er intron 4 polymorphisms) to be related to TTN.
  
  
  METHODS
  We screened genomic DNA of 83 healthy term neonates (gestational age: 39 (37 - 41) completed weeks [median and range]; birth weight: 3325 +/- 541 grams [mean +/- SD]) and 75 infants presenting with TTN (gestational age: 38 (37 - 41) completed wecks [median and range]; birth weight: 3091 +/- 435 grams [mean +/- SD]) by means of PCR-amplification, fragment length and sequence analysis. TTN was diagnosed an the basis of the clinical signs with respiratory rate > 60 breaths/minute, fraction of inspired oxygen > 0.21, and characteristic radiographic findings within less than 24 hours after birth. Newborns with any infection, pulmonary or cardiac congenital malformations, postnatal asphyxia and infants born to diabetic mothers were excluded.
  
  
  RESULTS
  In TTN-group the frequency of male infants (68.4 % versus 44.6 %, p < 0.05) and caeserian section were significantly higher (68.4 % versus 30.1 %, p < 0.05). We did not find any statistical difference in frequency of intron 4 variations between controls and TTN-group (8.4 % versus 10.7 %). None of the infants were heterozygous for the 121ins2 SP-B mutation.
  
  
  CONCLUSIONS
  WC conclude polymorphisms of intron 4 and heterozygous 121 ins 2 mutation not to associated with TTN.
authors.affiliation: Pediatric Center, Department of Pediatrics and Neonatology, Justus-Liebig-University, Giessen, Germany. erol@tutdibi.de
authors.forename: E
authors.initials: E
authors.lastname: Tutdibi
authors.forename: B
authors.initials: B
authors.lastname: Hospes
authors.forename: E
authors.initials: E
authors.lastname: Landmann
authors.forename: L
authors.initials: L
authors.lastname: Gortner
authors.forename: M
authors.initials: M
authors.lastname: Satar
authors.forename: M
authors.initials: M
authors.lastname: Yurdakök
authors.forename: H
authors.initials: H
authors.lastname: Dellagrammaticas
authors.forename: R
authors.initials: R
authors.lastname: Ors
authors.forename: B
authors.initials: B
authors.lastname: Ilikkan
authors.forename: F
authors.initials: F
authors.lastname: Ovali
authors.forename: G
authors.initials: G
authors.lastname: Sarman
authors.forename: A
authors.initials: A
authors.lastname: Kumral
authors.forename: S
authors.initials: S
authors.lastname: Arslanoglu
authors.forename: H
authors.initials: H
authors.lastname: Koc
authors.forename: A
authors.initials: A
authors.lastname: Yildiran
mesh_terms: D000367:Age Factors; D001724:Birth Weight; D002585:Cesarean Section; D005260:Female; D014644:Genetic Variation; D005865:Gestational Age; D006579:Heterozygote; D006801:Humans; D007231:Infant, Newborn; D007438:Introns / Q000235:genetics; D008297:Male; D009154:Mutation; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D037701:Pulmonary Surfactant-Associated Protein B / Q000235:genetics*; D012120:Respiration Disorders / Q000175:diagnosis / Q000209:etiology / Q000235:genetics*; D012127:Respiratory Distress Syndrome, Newborn / Q000235:genetics; D012307:Risk Factors; D012737:Sex Factors; D013997:Time Factors
chemical_list: D037701:Pulmonary Surfactant-Associated Protein B